|
Rompag 25 mg Tablet is indicated for the treatment of low platelet counts in patients with chronic immune thrombocytopenic purpura (ITP) and those with chronic hepatitis C virus (HCV) infection. It is also effective in managing severe aplastic anaemia.
As a thrombopoietin receptor agonist, Rompag works by stimulating the production of new platelets, which play a critical role in minimizing bleeding and supporting blood health. To know more call
|